JFMS is a truly international journal, and so, as well as covering disease conditions of cats that are present the world over, it has a duty to cover important regional diseases. One such disease is tick paralysis in cats.
In the USA, there are two main species of tick capable of producing paralysis, Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), with most cases occurring in the Rocky Mountain States, the Pacific Northwest and south-eastern states between late spring and early summer. The tick paralysis that results from such envenomations seems relatively mild based on the paucity of reports of feline disease in the literature. It is fair to say that, in the USA, there is more focus on the diseases that can be transmitted by ticks, rather than diseases due to direct effects of ticks on the host.
A very different situation exists along the east coast of Australia where tick paralysis caused by Ixodes holocyclus is an incredibly important disease in companion animals, including the cat (Figure 1) , and is one of the most common preventable causes of death of dogs and cats in this region. Typical hosts for the paralysis tick are native Australian marsupials such as bandicoots, macropods and possums. Under usual circumstances the ectoparasite generally causes few adverse effects in these hosts as they are exposed to small numbers of nymphs and adult ticks at the beginning of the tick season (spring), thereby generating acquired resistance to the toxin (largely due to antibodies). Cats, dogs and people, however, normally have little in the way of immunity to a tick's salivary neurotoxin, especially at the start of the tick season, and are thus vulnerable to envenomation. Indeed, one tick can be sufficient to paralyse a cat.
The specific neurotoxin in the saliva of I holocyclus that causes tick paralysis is holocyclotoxin. This is a cystine knot neurotoxin that acts presynaptically to reduce quantal release of acetylcholine from the motor nerve terminals at the neuromuscular junction. Typically, after 3-4 days there is sufficient envenomation for muscle weakness and eventually paralysis to develop.
Cats become agitated, perhaps as they do not understand 'what is happening'; in addition, there are other issues such as weakness of the pharynx, and the propensity to aspirate saliva due to laryngeal and oesophageal weakness. This is a life-threatening condition in many cats, especially when owners are not 'switched on' to early signs of the disease.
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It is rare in feline medicine to have so much evidence upon which to draw conclusions and make recommendations
It is interesting that such a rigorous and scholarly study was performed from a private practice base, rather than a university veterinary teaching hospital. The size of the caseload, high standard of case management and presence of defined practice guidelines for case management and clinical decision-making underpin the rigor and scholarship of the work. I don't want to say much more about what they found, however -because it's all in the paper! New research makes up for lost time on feline tick paralysis
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In feline medicine, prevention is always more important than cure
The recent availability of three novel prophylactic medications has produced a huge step forward for canine patients. The first drug to be released was fluralaner (Bravecto; MSD Animal Health), from a new class of isoxazoline antiparasitic drugs that act on gamma-aminobutyric acid-(GABA-) and glutamate-gated chloride channels in arthropods (ticks and insects including fleas). Because of highly favourable pharmacokinetics, one fluralaner tablet of the correct size will protect dogs against tick paralysis for 4 months or longer, and will also be effective against flea infestation for 3 months (Australian studies show 100% efficacy against paralysis ticks at 4 months and 96% efficacy at 5 months in dogs 2 ). Merial Animal Health has a similar drug, afoxolaner (NexGard), which needs to be given once a month, and a third drug is sarolaner (Simparica) from Zoetis, another once-a-month prophylactic. Veterinarians up and down the east coast of Australia have observed a sharp reduction in the number of dogs presented for tick paralysis since the widespread availability of these new drugs in the market, and this has been mirrored by the observation of veterinary insurance companies (fewer claims!). We are therefore pretty sure these new products are doing exactly what they are supposed to do.
Unfortunately none of these are currently available for cats, and so we are left with fewer effective propositions such as the clever Seresto collar from Bayer Animal Health, fipronil sprays (which cats invariably hate) and fipronil top-spot products, and old standbys such as combing the cat once a day with a flea comb to locate and remove any attached ticks (remember it takes 3-4 days for the cat to develop signs).
In the USA, Bravecto is available for cats as a topical solution, but the Australian Pesticides and Veterinary Medicines Authority is proving frustratingly slow to process the registration of this important new drug to prevent tick paralysis in cats. In the interim, Australian vets are forced to use the same doses of fluralaner off label to afford protection to cats in endemic areas. It is absolutely vital that isoxazolines are made available to prevent the morbidity, mortality and enormous cost of this devastating disease to the Australian feline population. This patient is much more severely affected, and after similar preliminary therapy has been placed on a ventilator. The treatment of such cases is intensive and expensive; often they are referred to 24 h intensive care facilities for handling
